Andrew Griffiths

Andrew Griffiths

Auto-generated profile, based on publicly available information

Andrew Griffiths

Forensic Toxicology, Forensic Pathology and Coronial Services Queensland Health Brisbane Queensland Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Clinical Toxicology
Verified
Journal Article
Closed access
RSRebekka Syrjanen
Rebekka Syrjanen
JSJennifer Schumann
Jennifer Schumann
JCJared Castle
Jared Castle
LSLesley Sharp
Lesley Sharp
AGAndrew Griffiths
Andrew Griffiths
SGShaun L. Greene
Shaun L. Greene
Protonitazene is an opioid belonging to the 2-benzylbenzimidazole structural class. We describe two cases of opioid toxicity involving the reported inhalation of a delta-9-tetrahydrocannabinol vape product in which protonitazene was detected. Case 1 was a young male found unconscious after the reported use of a delta-9-tetrahydrocannabinol vape. He suffered two subsequent apnoeic episodes requiring bag-valve-mask ventilation before eventual recovery. Only protonitazene was detected in blood at a concentration of 0.74 µg/L. Case 2 was a young male who died shortly after being found unresponsive. The postmortem femoral blood concentrations of protonitazene and delta-9-tetrahydrocannabinol were 0.33 µg/L and 2 µg/L, respectively. Analysis of a pod vaping device found in the decedent's hand and a separate e-liquid bottle labelled as delta-9-tetrahydrocannabinol showed a mixture of protonitazene and delta-9-tetrahydrocannabinol. The opioid effects of protonitazene are mediated through β-arrestin2 and mu opioid receptor signalling pathways. Benzimidazole opioids are lipophilic and, when mixed with a suitable solvent, can be used in a vape device. It is anticipated that naloxone would have provided effective reversal of toxicity in our cases. Novel routes of opioid administration, like vaping, may appear relatively innocuous in comparison to intravenous administration, but opioids may still be absorbed at high concentrations, resulting in severe opioid toxicity or death.


2 September 2023 in Clinical Toxicology
Verified
Journal Article
Closed access
KIKatherine Z. Isoardi
Katherine Z. Isoardi
DRDarren M. Roberts
Darren M. Roberts
AHAmanda G. Holford
Amanda G. Holford
JBJared A. Brown
Jared A. Brown
AGAndrew Griffiths
Andrew Griffiths
SGShaun Greene
Shaun Greene
Poppy seed tea is used for its opioid effects and contains multiple opium alkaloids, including morphine, codeine, papaverine, and thebaine. Animal studies indicate thebaine has strychnine-like properties, but there is limited literature describing human thebaine poisoning. We describe a cluster of acute thebaine poisoning in people ingesting tea made using poppy seeds with high thebaine content that entered the Australian food supply chain. This is an observational study of patients poisoned after drinking poppy seed tea. Cases were identified by three prospective toxicovigilance systems: the Emerging Drug Network of Australia collaboration, the New South Wales Prescription, Recreational and Illicit Substance Evaluation program, and the Emerging Drugs Network of Australia Victoria study. We report characteristics of clinical toxicity in cases with reported ingestion of poppy seed tea and analytical confirmation of thebaine exposure. Forty cases presenting with multi-system toxicity following poppy seed tea ingestion were identified across seven Australian states/territories from November 2022 to January 2023. Blood testing in 23 cases confirmed high thebaine concentrations. All 23 were male (median age 35, range 16-71 years). All patients experienced muscle spasms. Rigidity was described in nine, convulsions in six, while rhabdomyolysis, acute kidney injury, and metabolic acidosis occurred in five patients. There were two cardiac arrests. The thebaine median admission blood concentration was 1.6 mg/L, with a range of 0.1-5.6 mg/L, and was the dominant opium alkaloid in all samples. Convulsions, acute kidney injury, metabolic acidosis, and cardiac arrest were associated with increasing median thebaine concentrations. Four patients were managed in the Intensive Care Unit, with two receiving continuous kidney replacement therapy (one also received intermittent haemodialysis) for kidney injury. There was one death. Thebaine toxicity, like strychnine poisoning, resulted in neuromuscular excitation characterized by muscle spasm, rigidity, and convulsions. Severe toxicity, including acute kidney injury, metabolic acidosis, and cardiac arrest, appears dose-dependent.

1 April 2021 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
AGA. Griffiths
A. Griffiths
NMN. Milne
N. Milne
BOB. Ong
B. Ong
TWT. Watkins
T. Watkins

26 September 2026 in Journal of Forensic Sciences
Verified
Journal Article
Open access
AGAndrew Griffiths
Andrew Griffiths
NMNathan Milne
Nathan Milne
MJMichelle Johnston
Michelle Johnston
KBKaren Blakey
Karen Blakey
RSRogan Scott
Rogan Scott
Multiple new analogues from the 2‐benzyl benzimidazole or “nitazene” class of drugs have emerged on the drug market in recent years. Nitazenes are highly potent μ‐opioid receptor agonists that present a substantial public health concern due to their elevated risk of severe toxicity in overdose and their significant potential for misuse. We report on a case involving an overdose with another new analogue from this class, protodesnitazene. The drug has a similar potency to fentanyl and has not been previously reported in toxicology specimens or drug seizures. Protodesnitazene was initially identified by LC‐QTOF–HRMS (High Resolution Mass Spectrometry) and distinguished from relevant isomers by chromatographic separation, with spectral and retention time matching against reference standards. A quantitation method employing solid phase extraction using mixed mode cartridges and utilizing LC–MS/MS operating in MRM mode was developed and partially validated for non‐routine analyses. Concentrations for the parent drug were determined in a range of postmortem matrices and femoral blood levels (77–222 ng/mL) were found to be comparable to previously identified desnitazene compounds. Protodesnitazene was observed to metabolize extensively by N‐dealkylation, O‐dealkylation, and hydroxylation. Glucuronides were not present at high levels in the blood but were prominent in the urine. Protodesnitazene was also identified in an associated seized powder.